Clinical Trial Update: Comparative Expression of ER,PR and HER2/Neu in Initial and Recurrent Breast Cancer.

View source ↗

Summary

An ongoing study at Sohag University compares ER, PR, and HER2/Neu expression between initial and recurrent breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Sohag University | Conditions: Breast Cancer | Status: ENROLLING_BY_INVITATION